{
  "ticker": "JNJ",
  "target_date": "2024-12-16",
  "actual_date": "2024-12-16",
  "collected_at": "2025-12-08T11:09:11.157684",
  "price": {
    "open": 142.37,
    "high": 142.88,
    "low": 139.26,
    "close": 139.5774383544922,
    "volume": 8732400,
    "change_1d_pct": -1.89,
    "change_7d_pct": -3.79,
    "change_30d_pct": -9.45
  },
  "technicals": {
    "rsi_14": 11.24,
    "sma_20": 146.69,
    "sma_50": 150.96,
    "macd": -2.673,
    "macd_signal": -2.108,
    "macd_histogram": -0.565,
    "bb_upper": 153.37,
    "bb_lower": 140.0,
    "price_vs_sma20_pct": -4.85,
    "price_vs_sma50_pct": -7.54,
    "volume_ratio": 1.04
  },
  "fundamentals": {
    "market_cap": 488797798400,
    "pe_ratio": 19.583014,
    "forward_pe": 19.139622,
    "price_to_book": 6.1577687,
    "price_to_sales": 5.3044286,
    "profit_margin": 27.26,
    "operating_margin": 30.2,
    "roe": 33.62,
    "roa": 8.26,
    "revenue_growth": 6.8,
    "earnings_growth": 91.0,
    "debt_to_equity": 57.766,
    "current_ratio": 1.074,
    "quick_ratio": 0.711,
    "dividend_yield": 258.0,
    "fifty_two_week_high": 207.81,
    "fifty_two_week_low": 140.68,
    "fifty_day_avg": 193.4922,
    "two_hundred_day_avg": 170.2741,
    "analyst_target": 203.41833,
    "analyst_recommendation": "buy",
    "num_analysts": 24,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - General",
    "pct_from_52w_high": -2.37,
    "pct_from_52w_low": 44.21
  },
  "macro": {
    "spy": {
      "price": 599.5,
      "change_1d_pct": 0.43,
      "change_7d_pct": -0.17
    },
    "vix": {
      "level": 14.69,
      "signal": "LOW_FEAR"
    },
    "treasury_10y": {
      "yield_pct": 4.4
    },
    "dollar_index": {
      "level": 106.86
    },
    "gold": {
      "price": 2651.4
    },
    "regime": "BEAR_NORMAL"
  },
  "news": [
    {
      "headline": "Johnson & Johnson (JNJ) Stock Declines While Market Improves: Some Information for Investors",
      "source": "Yahoo",
      "datetime": 1734389117,
      "summary": "In the most recent trading session, Johnson & Johnson (JNJ) closed at $143.85, indicating a -1.89% shift from the previous trading day.",
      "url": "https://finnhub.io/api/news?id=5fc2a8a9239b27e1616df2d823adefd781bed007a92e1f011806c81bb4e3ede1"
    },
    {
      "headline": "Market Chatter: Johnson & Johnson Sues Cigna Units Over Alleged Drug Fund Misuse",
      "source": "Yahoo",
      "datetime": 1734375930,
      "summary": "Johnson & Johnson (JNJ) is suing Cigna's divisions, Express Scripts and Accredo, claiming they worke",
      "url": "https://finnhub.io/api/news?id=c3beaaceebb4bb22fa36dd32e15f52a89cb3380c2622e2e194f3a74f648f422f"
    },
    {
      "headline": "Johnson & Johnson stock underperforms Monday when compared to competitors",
      "source": "MarketWatch",
      "datetime": 1734366660,
      "summary": "Johnson & Johnson stock underperforms Monday when compared to competitors",
      "url": "https://finnhub.io/api/news?id=f1ef80d76d5a2b51971174c3b06decdb5125dc648ed712d0eb5308b2a0408d78"
    },
    {
      "headline": "Dow's 111-point drop led by losses for UnitedHealth, Verizon shares",
      "source": "MarketWatch",
      "datetime": 1734364320,
      "summary": "Dow's 111-point drop led by losses for UnitedHealth, Verizon shares",
      "url": "https://finnhub.io/api/news?id=b19113b4252df7683d22d1790a148b167c7d01ac120864d66f09a3e6c3766695"
    },
    {
      "headline": "EMA Panel Endorses Lilly's Omvoh for Expanded Use in Crohn's Disease",
      "source": "Yahoo",
      "datetime": 1734351780,
      "summary": "The CHMP's opinion is based on late-stage data, which show that LLY's Omvoh is effective in Crohn's disease patients with or without prior biologic failure.",
      "url": "https://finnhub.io/api/news?id=521b4a3c62765effaf186c598570ecb2b51c468ba4416fff3cee3a4eba952d87"
    }
  ],
  "news_count": 5,
  "sec_filings": [
    {
      "form": "4",
      "date": "2024-12-12",
      "description": "xslF345X05/wk-form4_1734042449.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040624000106/xslF345X05/wk-form4_1734042449.xml"
    },
    {
      "form": "4",
      "date": "2024-12-12",
      "description": "xslF345X05/wk-form4_1734041779.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040624000104/xslF345X05/wk-form4_1734041779.xml"
    },
    {
      "form": "4",
      "date": "2024-12-12",
      "description": "xslF345X05/wk-form4_1734041373.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040624000102/xslF345X05/wk-form4_1734041373.xml"
    },
    {
      "form": "13F-HR",
      "date": "2024-11-13",
      "description": "xslForm13F_X02/primary_doc.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000090445424000604/xslForm13F_X02/primary_doc.xml"
    },
    {
      "form": "10-Q",
      "date": "2024-10-23",
      "description": "jnj-20240929.htm",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040624000096/jnj-20240929.htm"
    }
  ],
  "sec_filings_count": 5,
  "data_quality": {
    "has_price": true,
    "has_technicals": true,
    "has_fundamentals": true,
    "has_macro": true,
    "has_news": true,
    "has_sec_filings": true
  }
}